Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation by Nita A Limdi, Nita A Limdi

Connect to this object online.

Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples by Brittney H. Davis, Gina DeFrank, Nita A. Limdi, Shuko Harada

Connect to this object online.

Evaluation of population‐level pharmacogenetic actionability in Alabama by Brittney H. Davis, Kelly Williams, Devin Absher, Bruce Korf, Nita A. Limdi

Connect to this object online.

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients by Alessandra M. Campos-Staffico, Michael P. Dorsch, Geoffrey D. Barnes, Hao-Jie Zhu, Nita A. Limdi, Jasmine A. Luzum

Connect to this object online.

Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis by Justin D. Anderson, Brittney H. Davis, Gracie Giang, April Jones, Cameron R. Lee, Kennedy Parker, Heather Searcy, Kim Benner, Nita A. Limdi, Jennifer S. Guimbellot

Connect to this object online.

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy by Sony Tuteja, Ramzi G. Salloum, Amanda L. Elchynski, D. Max Smith, Elizabeth Rowe, Kathryn V. Blake, Nita A. Limdi, Christina L. Aquilante, Jill Bates, Amber L. Beitelshees, Amber Cipriani, Benjamin Q. Duong, Philip E. Empey, Christine M. Formea, J. Kevin Hicks, Pawel Mroz, David Oslin, Amy L. Pasternak, Natasha Petry, Laura B. Ramsey, Allyson Schlichte, Sandra M. Swain, Kristen M. Ward, Kristin Wiisanen, Todd C. Skaar, Sara L. Van Driest, Larisa H. Cavallari, Jeffrey R. Bishop, for the IGNITE Pharmacogenetics Working Group

Connect to this object online.